Trial intelligence / Profile preview

Pentoxifylline for diabetic nephropathy-associated chronic kidney disease

2007-005985-10Phase 2Active

Sponsor
Juan Francisco Navarro González
Start
Jan 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, single-arm trial of pentoxifylline in diabetic glomerulosclerosis and chronic kidney disease (CKD), sponsored by Juan Francisco Navarro González. Primary endpoint: Mean rate of progression of serum creatinine. Started Jan 2008; status: active.

02

Drugs

pentoxifylline
03

Conditions

diabetic glomerulosclerosischronic kidney disease (CKD)

Beyond the preview

Go deeper on 2007-005985-10.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-005985-10.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call